Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Indolent Non-Hodgkin Lymphoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma by Clinical Course
Indolent Non-Hodgkin Lymphoma

Hematologic Malignancy

Indolent Non-Hodgkin Lymphoma

CI-CAN-00005564Explore in graph →

Hematologic212 active trials12 approved drugs2 evidence items

NCIt: C8504

Overview
Statistics
Survival
Genomics
Variants & evidence2
Drugs3
Trials791
Research
Rankings
Sources & provenance

Data completeness4 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A non-Hodgkin lymphoma with an indolent clinical course.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Non-Hodgkin Lymphoma by Clinical CourseOther

Children (3)

ncit

Indolent Adult Non-Hodgkin Lymphoma1 sub
Indolent B-Cell Non-Hodgkin Lymphoma7 sub
Indolent T-Cell Non-Hodgkin Lymphoma3 sub

75 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Hematopoietic and Lymphatic SystemC35813

Record

Identity

CancerIndex ID: CI-CAN-00005564
Entity type: Hematologic Malignancy
Malignant: Yes
Solid / hematologic: Hematologic
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 6
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

791 / 212

Publications (all / 5y)

1,291 / 387

Evidence items

2

Genes / variants

1 / 1

Drugs (any / approved)

3 / 12

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (4)

Indolent lymphomasynonym · NCIt
Indolent Non-Hodgkin's Lymphomasynonym · NCIt
NHL, indolent, NOSsynonym · NCIt
Non-Hodgkin lymphoma, indolent, NOSsynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

US deaths19,882countUnited States · 2024 · both sexes · all agescdc-wonderObservedrank #8 of 31 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
US new cases75,946countUnited States · 2023 · both sexes · all agescdc-uscsObservedrank #8 of 32 (USA · both sexes · all ages · 2023 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
US age-standardized mortality4.5per 100,000United States · 2024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderObservedrank #7 of 23 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
Active trials212countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #137 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials103countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #143 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items2countaccepted CIViC items · entity + descendantscivicComputedrank #342 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months83countPubMed records · stored query · 12-month windowpubmedComputedrank #370 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 18 hours agoSource updated unknownregistry figures: cdc-uscs · latest year available per metric · counters aggregate over descendants